Is HemoHIM FDA Approved? Regulatory Status Explained [2026]
Clear explanation of HemoHIM's FDA status, Kolmar BNH facility registration, NAI classification, Australian TGA recognition, and what it all means for consumers.
"Is HemoHIM FDA approved?" is one of the most common questions about this supplement. The short answer: HemoHIM's manufacturer, Kolmar BNH, has received FDA facility registration and NAI (No Action Indicated) status after inspection — a significant quality endorsement. But "FDA approved" and "FDA registered" mean different things. Here's exactly what HemoHIM's regulatory status means.
FDA Registration vs FDA Approval: The Key Difference
This distinction matters because many consumers confuse the two terms:
- FDA Approval means the FDA has reviewed clinical trial data and determined a drug is safe and effective for a specific medical condition. This applies to prescription and over-the-counter drugs — not dietary supplements.
- FDA Facility Registration means the manufacturing facility is registered with the FDA and has been inspected. An NAI (No Action Indicated) result means the FDA found no significant violations during inspection — the best possible outcome.
No dietary supplement in the United States is "FDA approved" — this includes vitamins, minerals, probiotics, and herbal supplements like HemoHIM. The FDA does not approve supplements before they are sold. What it does is register and inspect manufacturing facilities to ensure they follow Good Manufacturing Practices (GMP).
Kolmar BNH and the FDA: What Actually Happened
Kolmar BNH (KRX: 200130), the manufacturer of HemoHIM, achieved two important regulatory milestones. This was covered by Business Wire and other outlets as international recognition for HemoHIM's quality:
FDA Facility Registration & NAI Status
Kolmar BNH's manufacturing facility was inspected by the FDA. The result was NAI — No Action Indicated — meaning the FDA found no significant deviations from Good Manufacturing Practices. This is the highest classification an FDA inspection can receive. It confirms that HemoHIM is produced in a facility that meets U.S. manufacturing standards for dietary supplements.
Australian TGA Recognition
Australia's Therapeutic Goods Administration (TGA) is known for having some of the most stringent supplement regulations in the world. HemoHIM received TGA recognition, which provides additional international validation of its quality and manufacturing standards. The TGA evaluates safety, quality, and efficacy of therapeutic goods.
Other HemoHIM Certifications
Beyond FDA and TGA, HemoHIM and its manufacturer hold several quality certifications. You can learn more on our Atomy HemoHIM product page:
- GMP (Good Manufacturing Practices): Certified manufacturing following international pharmaceutical-grade standards
- HACCP (Hazard Analysis Critical Control Points): Food safety management system certification
- Korean MFDS (Ministry of Food and Drug Safety): Recognized as an Individual Health Functional Food — a specific regulatory category in South Korea for products with demonstrated health benefits
- Patented formulation: Developed by KAERI (Korea Atomic Energy Research Institute) with 8 years of government-funded research
Clinical Safety Evidence
While FDA registration confirms manufacturing quality, HemoHIM also has published safety data from clinical studies:
- 8-week randomized, double-blind, placebo-controlled human safety trial — no significant adverse effects
- 13-week repeated dose toxicity study — no organ damage at doses far exceeding recommended intake (liver safety details)
- Multiple published studies in peer-reviewed journals (PubMed indexed)
What About the Hong Kong Advisory?
In 2023, Hong Kong's health authority issued an advisory about HemoHIM after a single case of acute hepatitis. For a detailed, evidence-based analysis of this case and what it means in the context of clinical trial data, see our HemoHIM liver safety analysis.
Bottom Line
HemoHIM is not "FDA approved" — but no dietary supplement is. What it does have is FDA facility registration with NAI status (the best inspection result), Australian TGA recognition, GMP and HACCP certifications, Korean MFDS recognition as an Individual Health Functional Food, and published clinical safety data. For a complete overview of HemoHIM, including its development, ingredients, and research, start with our full guide.
❓ Is HemoHIM approved by the FDA?
HemoHIM is not FDA approved — no dietary supplement is. The FDA does not approve supplements before sale. However, HemoHIM's manufacturer Kolmar BNH has FDA facility registration and received NAI (No Action Indicated) status after FDA inspection, meaning the facility meets U.S. Good Manufacturing Practices standards.
❓ What does FDA NAI status mean for HemoHIM?
NAI (No Action Indicated) is the best possible result from an FDA facility inspection. It means the FDA found no significant violations of Good Manufacturing Practices. This confirms that HemoHIM is produced in a facility that meets U.S. manufacturing quality standards for dietary supplements.
❓ Is HemoHIM banned in any country?
HemoHIM is not banned in any country. It is sold through Atomy in multiple markets worldwide. Hong Kong issued an advisory in 2023 after a single case report, but this was a consumer warning, not a ban. HemoHIM continues to be legally sold and distributed internationally.
❓ What certifications does HemoHIM have?
HemoHIM holds multiple certifications: FDA facility registration with NAI status, Australian TGA recognition, GMP (Good Manufacturing Practices), HACCP food safety certification, and Korean MFDS recognition as an Individual Health Functional Food. It was developed with a patent by KAERI, South Korea's nuclear research institute.
See the full list of HemoHIM certifications and Atomy company details in our comprehensive review.
Ready to try HemoHIM? Register through our official Atomy link — free membership, no purchase obligation.